Alnylam Competitors and Similar CompaniesClear all
Celyad's competitors and similar companies include Sorrento Therapeutics.
 Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. |  Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| |
Founding Date | Founding Date 2007 | Founding Date 2006 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | Locations San Diego, US HQ San Diego, US |
Employees | Employees 17 | Employees 31019% decrease |
Valuation ($) | Valuation ($) 11.8 m | Valuation ($) 1.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) €102k (FY, 2023) | Revenue (est.) $62.8m (FY, 2022) |
Net income | Net income (€8.4m) (FY, 2023) | Net income ($577.8m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Sorrento Therapeutics
HQ
San Diego, US
Employees
310↓ 19% decrease
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company